Warf Cmpd. 42 en es it fr

Warf Cmpd. 42 Brand names, Warf Cmpd. 42 Analogs

Warf Cmpd. 42 Brand Names Mixture

  • No information avaliable

Warf Cmpd. 42 Chemical_Formula

C19H16O4

Warf Cmpd. 42 RX_link

http://www.rxlist.com/cgi/generic/warfarin.htm

Warf Cmpd. 42 fda sheet

Warf_Cmpd._42 FDA

Warf Cmpd. 42 msds (material safety sheet)

Warf_Cmpd._42 MSDS

Warf Cmpd. 42 Synthesis Reference

Stahmann, et al., U.S. Pat. 2,427,578 (1947)

Warf Cmpd. 42 Molecular Weight

308.328 g/mol

Warf Cmpd. 42 Melting Point

161 oC

Warf Cmpd. 42 H2O Solubility

17 mg/L

Warf Cmpd. 42 State

Solid

Warf Cmpd. 42 LogP

3.505

Warf Cmpd. 42 Dosage Forms

Powder for solution; Tablet

Warf Cmpd. 42 Indication

For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.

Warf Cmpd. 42 Pharmacology

Warfarin, a coumarin anticoagulant, is a racemic mixture of two active isomers. It is used in the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).

Warf Cmpd. 42 Absorption

No information avaliable

Warf Cmpd. 42 side effects and Toxicity

LD50=374 (orally in mice)

Warf Cmpd. 42 Patient Information

No information avaliable

Warf Cmpd. 42 Organisms Affected

Humans and other mammals